Protocol Ledger

NCT07452458 · Phase III · RECRUITING

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Interventional Phase III clinical trial protocol NCT07452458 sponsored by NRG Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-07-16 Enrollment: 398 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07452458
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)398 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07452458
Protocol FieldVerified Registry Value
NCT IdentifierNCT07452458
Consolidated Lead SponsorNRG Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment398 participants (ESTIMATED)
Registered Start Date2026-07-16
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI